Trial intelligence / Profile preview

Itacitinib in chronic plaque psoriasis

NCT01634087Phase 2Completed

Sponsor
Incyte
Start
Jun 2012
Primary completion
Jan 2013
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of itacitinib in plaque psoriasis, sponsored by Incyte. Started Jun 2012; status: completed.

02

Drugs

itacitinib
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01634087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01634087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call